Ireland
--:--IST
Recruiting Not applicable

Direct In-Scope Suction Versus Standard Flexible Ureterorenoscopy

NCT07864194 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-07-07
Last updated
2026-10-07

Condition(s) studied

Renal Stone Disease

Investigational drug(s) / intervention(s)

Standard flexible ureterorenoscopeFlexible ureterorenoscope with direct in-scope suction

Standard flexible ureterorenoscope: A 7.5 Fr reusable Storz Flex-X2 flexible ureterorenoscope without direct in-scope suction will be used for retrograde intrarenal surgery. Stone fragmentation will be performed with a Holmium:YAG laser through a 9.5/11.5 Fr ureteral access sheath.

Flexible ureterorenoscope with direct in-scope suction: A 7.5 Fr single-use Claritron flexible ureterorenoscope equipped with direct in-scope suction will be used for retrograde intrarenal surgery. Suction through the scope will be available during irrigation and Holmium:YAG laser lithotripsy. A 9.5/11.5 Fr ureteral access sheath will be used.

Study summary

This prospective study aims to compare the clinical, perioperative, and postoperative outcomes of flexible ureterorenoscopy using a direct in-scope suction system (DISS) with standard flexible ureterorenoscopy in patients undergoing retrograde intrarenal surgery for renal or proximal ureteral stones. A total of 70 patients will be enrolled, with 35 patients in each group. The study will assess postoperative infectious complications, including fever, systemic inflammatory response syndrome (SIRS), and sepsis, as well as operative parameters, length of hospital stay, reoperation, and stone-free status. Stone-free status will be assessed by non-contrast computed tomography four weeks after surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older. * A single stone located in the kidney or proximal ureter. * Scheduled to undergo retrograde intrarenal surgery (RIRS) by the study's surgical team. Exclusion Criteria: * Multiple renal or proximal ureteral stones. * Age younger than 18 years. * Pregnancy. * Preoperative urinary tract infection. * Bleeding diathesis.

Primary outcome measure(s)

  • Incidence of Postoperative Fever — Within 48 hours after surgery
    Number and percentage of participants with a recorded body temperature \>38°C within 48 hours after surgery.

Trial sites (1)

FacilityCityRegionStatus
Department of Urology, Hitit University Çorum Erol Olçok Training and Research Hospital, Çorum, Türkiye Çorum Çorum Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07864194 on ClinicalTrials.gov ↗ ← All trials in Turkey